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Abstract Early detection and appropriate treatment of hearing loss are essential to 
min-imise the consequences of hearing loss. In addition to conventional audiometry 
(125---8000 Hz), extended high-frequency audiometry (9000---20 000 Hz) is available. 
This type of audiometry may be useful in early diagnosis of hearing loss in certain 
conditions, such as the ototoxic effect of cisplatin-based treatment, noise exposure or 
oral misunderstanding, especially in noisy environments. Eleven examples are shown in 
which extended high-frequency audiometry has been useful in early detection of 
hearing loss, despite the subject having a normal conventional audiometry. The goal of 
the present paper was to highlight the importance of the extended high-frequency 
audiometry examination for it to become a standard tool in routine audiological 
examinations.  
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Resumen La detección precoz y el tratamiento adecuado de la hipoacusia es 
fundamental para minimizar las consecuencias de la pérdida auditiva. Además de la 
audiometría convencional (125-8.000 Hz), disponemos de la audiometría con extensión 
en altas frecuencias (9.000-20.000 Hz), que puede ser de gran utilidad en el 
diagnóstico precoz de hipoacusia en ciertas patologías, como es el efecto ototóxico de 
los tratamientos quimioterápicos, la exposición a ruido o el mal entendimiento del 
lenguaje, especialmente en ambientes ruidosos. Aquí se presentan 11 casos clínicos en 
los que la audiometría con extensión en altas frecuencias ha ayudado en la detección 
precoz de la hipoacusia en diversas patologías, a pesar de tener una audiometría 
normal en frecuencias convencionales. Se pretende así destacar la importancia de la 
exploración audiométrica en altas frecuencias, con el fin de que se convierta en una 
herramienta habitual en la exploración audiológica 
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Introduction Many factors are known to affect hearing, such as age, expo-sure to 
noise and taking potentially hearing-toxic drug. Both early detection of hearing loss 
and early intervention are essential to minimise hearing loss. Hearing is assessed 
through conventional tonal audiometry (125---8000 Hz). However, the human ear 
possesses an auditory range that reaches up to 20 000 Hz. Frequencies between 9000 
and 20 000 Hz are called extended high frequencies (EHFs) in the international 
literature. Castilian Spanish has no defined equivalent term; such frequencies are 
called high frequencies, ultra-high frequencies or extended high frequencies by 
different authors, with the last term being the one that we are going to use to refer to 
them. The involvement of EHFs in auditory pathology is multiple. They can affect 
locating the sound1 and understanding language, especially in noisy surroundings. 2,3 
They have also been linked with age-related hearing loss, ototoxicity and acoustic 
trauma. The ability to hear reduces bit by bit with age; this loss begins at the highest 
frequencies and progressively extends toward the lowest frequencies. The EHFs 
consequently become of special importance in age related hearing loss, as a method 
for early detection of such loss. An important role is played by EHF audiometry in 
monitoring the ototoxic effect of drugs such as cisplatin, which produces an initial 
hearing loss in the EHF range, later affecting conventional frequencies.4 However, the 
usefulness of EHF audiometry compared with conventional frequencies in early 
detection of acoustic trauma is still being debated.5-8 Reference hearing thresholds 
distributed by age groups have recently been published for both conventional 
frequencies 9 and EAF. 10,11These values let us compare a subject’s hearing with the 
standard for an ontologically normal population and establish the extent to which the 
subject’s hearing departs from normality expressed as a percentile. We can thus 
evaluate patients being treated with chemotherapy or exposed to noise that report a 
hearing loss and for whom there is no prior audiometry available. The objective of this 
study was to emphasise the importance of EHF audiometry, to help to make it a 
normal toolin audiological examination. To do so, we present a series of clinical cases 
in which this type of audiometry has aided in early detection of various pathologies. 
MethodsSubjects The data for 11 subjects that consulted with suspicion of auditory 
pathology have been gathered. Each subject’s audiometry at conventional frequencies 
was normal, and we performed an EHF audiometry on all the subjects (Table 1).The 
patients selected presented several pathologies that can cause hearing loss over the 
evolution of the disease.  
Instrumental and Procedure All selected subjects received air conduction pure tone 
audiometry to determine the hearing threshold at different frequencies (125---20 000 
Hz). The audiometric results obtained were compared with the previously, published 
normal Spanish population values at conventional frequencies 9 and at EAFs. 10 For the 
conventional frequency audiometry at conventional frequencies (125---8000 Hz), a 
Madsen Orbiter 922clinical audiometer and supra-aural Telephonics TDH-39 ear-
phones were used. The EHF audiometry (9000---20 000 Hz) was performed with the 
same audiometer and Koss HV/1Acircumaural earphones. All the audiometric material 
was calibrated according to the manufacturers’ recommendations as well as to ISO 
389-1 12 and IEC 60645-1 13 standards.The transducers were calibrated according to 
ISO 389-1 12 standards.The audiometry was performed manually by trained personnel, 
in agreement with ISO 8253-114standards, with in a sound-proof booth. Auditory 
thresholds were determined based on the ascending method established in ISO 8253-
114standards. The thresholds at the conventional frequencies were calculated in 
decibels hearing level (dB HL) and the thresholds at EHFs, in dB sound pressure level 
(dB SPL). 
Results Table 1 presents a summary of the characteristics of the subjects on which 
audiometry was performed using both conventional frequencies and EHFs. Cases 1, 2, 
and 3 presented normal hearing levels up to 8000 Hz, with a drop to under the 95th 
percentile (P95)for their age group (20---29 years) at the frequencies from9000 Hz 
(Fig. 1). 
Case 4, who had been a musician in a rock group for 2 years, presented a hearing level 
lower than P95 only at the frequencies of 9000, 11 200 and 12 500 Hz (Fig. 1). The 
frequencies at which the subject departed most from the median were 12 000 and 16 
000 Hz. Case 5 was a 26-year-old woman with sinonasal carcinoma, who had received 
treatment with radiotherapy and 3 cycles of cisplatin a year earlier. She presented a 
hearing level lower than P95 from 4000 Hz (Fig. 1).Case 6, who reported difficulties 
understanding in noisy surroundings, presented a hearing level very close to the 
median for his age group (30---39 years), with a drop to underP95 at frequencies from 
14 000 Hz (Fig. 2).Cases 7, 8 and 9 presented hearing levels lower than P95from 9000, 
8000 and 4000 Hz, respectively (Fig. 2).Case 10 reported having tinnitus without 
hearing loss. Audiometry revealed a hearing level below P95 for the subject’s age 
group (40---49 years) from 9000 Hz. Hearing at all the conventional frequencies was 
very close to the median for the age group (Fig. 3).Case 11, a 45-year-old man that 
had received treatment with cyclophosphamide, methotrexate and 5-fluorouracil, 
presented a hearing level under P95 from 9000 Hz. Audiometry in conventional 
frequencies was normal, although it was very close to P95 at 500 and 2000 Hz (Fig. 3). 
Discussion Certain systemic pathologies can cause sensorineural hearing loss, which 
can be detected early by performing EHF audiometry. Fabry disease is a hereditary x-
linked lysosomal storage disease. Within the clinical picture this disease produces is 
sensorineural hearing loss. In Case 1, the subjects howed no hearing loss, with normal 
audiometry at conventional frequencies, which could lead us to believe that this 
subject presented no hearing compromise. However, when EHF audiometry was 
performed, an important loss at all the frequencies between 9000 and 20 000 Hz was 
seen. Many patients come to consultation for tinnitus, with-out reporting hearing loss, 
as Cases 2 and 10 did. In Case2, the subject reported tinnitus and dizziness after 
usingminoxidil. Audiometry at conventional frequencies was nor-mal; however, the EHF 
audiometry revealed that the hearing thresholds were much below normal, a loss that 
could explain the tinnitus. Radiotherapy in the head area is another cause of 
sensorineural hearing loss. In Case 3, a patient treated with radiotherapy due to a 
nasopharyngeal carcinoma, presented a hearing loss that was only detectable in the 
EHF audiometry, especially at the frequencies between 9000 and16 000 Hz.  
Case 4 was a subject exposed to very loud music. A hearing loss could be seen in EHF 
audiometry, especially at the frequencies located between 11 200 and 14 000 Hz, 
departing further from the median at 12 000 and 16 000 Hz. Some authors have found 
that acoustic trauma affects the frequencies of 3000---6000 Hz and that it also affects 
EAF considerably, 5 especially at 14 000 Hz 6 and 16 000 Hz.7 EHF audiometry is more 
sensitive than conventional audiometry, particularly in young subjects, 7 although not 
all authors believe that EHF audiometry provides additional information. 8 
Consequently, we still do not have conclusive data to establish the usefulness of EHF 
audiometry in early detection of noise-induced hearing loss. The usefulness of EHF 
audiometry is well know in early detection of hearing loss in subjects submitted to 
platinum-derived chemotherapy treatments, with cisplatin being the drug that presents 
the greatest risk of developing ototoxic effects. Other chemotherapy drugs such 
asmethotrexate and cyclophosphamide are also known to cause sensorineural hearing 
loss. In Case 5, the patient was treated with cisplatin and, in the audiometry, a severe 
hearing loss was revealed, even detectable at the conventional frequencies (4000 Hz). 
It is important to point out that, although the hearing threshold was extremely 
reduced, hearing was maintained at all the frequencies up to 20 000 Hz. This is 
something that occurs in younger subjects, who preserve their hearing up to very high 
frequencies, even though their hearing is lower than normal (Fig. 1). In Case 11, the 
compromise in hearing could only be seen when the audiometry was performed at 
EHFs. The frequencies included between 500 and 4000 Hz have traditionally been 
considered to be the most important for understanding speech. The range of 
conversational frequencies of the human voice lies between 250 and 3000 Hz; 
however, it is true that some phonemes are located between 4000 and 8000 Hz, or 
even at higher frequencies, especially in fricative consonants.3 Understanding speech 
poor lyin noisy environments, as occurred in Case 6, could be explained by the hearing 
loss at the higher frequencies (in this case, at the frequencies above 14 000 Hz).Many 
cases with suspicion of deafness arising from genetic or autoimmune origin can benefit 
from performing an EHF audiometric test for early detection of the hearing loss. In 
Cases 7, 8 and 9, this loss of hearing was revealed at the EHFs, with greater or lesser 
compromise of the highest conventional frequencies. For all these reasons, EHF 
audiometry can be extremely useful in early detection of sensorineural hearing loss. 
Performance of EHF audiometry should consequently be established in normal clinical 
practice to expand the study of patient hearing ranges. 
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